Tao Chen | Cardiovascular Mortality | Best Researcher Award

Dr. Tao Chen | Cardiovascular Mortality | Best Researcher Award

Fujian Medical University | China 

Tao Chen is a distinguished medical professional and researcher in the field of endocrinology and metabolism, currently serving as an Associate Chief Physician at the Affiliated Longyan First Hospital of Fujian Medical University and as a postgraduate tutor at Fujian Medical University. With extensive clinical and academic experience, he has played a vital role in medical education, scientific research, and the advancement of endocrine medicine. His primary research interests encompass diabetes, insulin resistance, metabolic disorders, osteoporosis, and the role of vitamin D in neuropathy. Tao Chen has published five scholarly papers focusing on topics such as glucose regulation, serum irisin levels and their relationship with insulin sensitivity, the effects of exercise on metabolic indicators, and vitamin D3-related complications in type 2 diabetes. His publications have collectively received 25 citations across 5 documents, and he holds an h-index of 3, reflecting his consistent contribution to clinical and academic research. Beyond research, he is actively involved in multiple professional organizations, serving as a council and committee member in various endocrinology and diabetes societies. He is also the Vice Chairman of the Osteoporosis and Bone Mineral Salt Disease Branch of the Longyan Medical Association and serves as a food and drug safety expert for the Longyan Municipal People’s Government. Through his ongoing leadership, research, and mentorship, Tao Chen continues to make meaningful contributions to endocrinology and medical science.

Profiles: Scopus | Orcid

Featured Publications

Lai, X., & Chen, T. (2024). Association of serum uric acid to high-density lipoprotein cholesterol ratio with all-cause and cardiovascular mortality in patients with diabetes or prediabetes: A prospective cohort study. Frontiers in Endocrinology.

Lai, X., & Chen, T. (2024). Association between the triglyceride–glucose index and serum soluble Klotho in middle-aged and older adults from NHANES 2007–2016. Scientific Reports.

Chen, T., Xing, X., Huang, L., Tu, M., Lai, X., Wen, S., Cai, J., Lin, S., Zheng, Y., Lin, Y., et al. (2023). Efficacy and safety of high-dose intramuscular vitamin D₂ injection in type 2 diabetes mellitus with distal symmetric polyneuropathy combined with vitamin D insufficiency: Study protocol for a multicenter, randomized, double-blinded, and placebo-controlled trial. Frontiers in Endocrinology.

Chen, T. (2022). Type 2 diabetes mellitus complicated with atherosclerotic cardiovascular disease patient treated with semaglutide: A case report. Chinese Journal of Diabetes.

Xinyi Huang | Obesity | Best Researcher Award

Dr. Xinyi Huang | Obesity | Best Researcher Award

Gaozhou people's hospital | China

Author Profile:

Orcid

🌟 DR. XINYI HUANG: A DEDICATED PHYSICIAN AND CARDIOVASCULAR RESEARCHER

🎓 EARLY ACADEMIC PURSUITS

Dr. Xinyi Huang began her medical journey at Guangdong Medical University, where she pursued a Bachelor of Medicine in Anesthesiology from 2015 to 2020. During her undergraduate years, she displayed exceptional academic prowess and leadership abilities. She actively participated in academic competitions, earning several accolades such as the Excellence Award in the 4th National Undergraduate Anesthesiology Knowledge Competition and multiple school-level awards in anesthesiology imaging professional skill contests.

Her strong academic foundation led her to further her studies at Sun Yat-sen University, one of China’s leading medical institutions. There, she specialized in Internal Medicine (Cardiovascular Medicine) and completed her Master of Medicine at Sun Yat-sen Memorial Hospital between 2020 and 2023.

🏥 PROFESSIONAL ENDEAVORS

Dr. Huang’s clinical career commenced as a Resident Doctor at Sun Yat-sen University, where she honed her expertise in cardiovascular medicine. Following this, she joined Gaozhou People's Hospital in Guangdong in October 2024, where she currently serves in the Cardiovascular Department.

Her clinical work focuses on the diagnosis and management of atrial fibrillation, obesity-related cardiovascular risks, and other complex cardiovascular conditions, reflecting her research interests.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON OBESITY

Dr. Huang has actively contributed to the growing body of cardiovascular research. Her primary research areas include Atrial Fibrillation, particularly in patients with obesity and heart failure with preserved ejection fraction (HFpEF). She has co-authored significant academic papers addressing the association between body mass index (BMI), abdominal obesity, and the incidence of atrial fibrillation in heart failure patients.

Her research extends to exploring lipoprotein subgroups, such as HDL subtypes, and their influence on vascular inflammation in hypertensive patients, highlighting her multidisciplinary approach linking metabolism and cardiovascular health.

🌍 IMPACT AND INFLUENCE

Dr. Huang’s work contributes meaningfully to understanding how obesity and metabolic factors drive cardiovascular conditions like atrial fibrillation. Her research has been published in reputable journals such as Current Medical Research and Opinion and the Chinese Journal of Arteriosclerosis, enhancing clinical insights into cardiovascular disease prevention and management.

Her awards in anesthesiology and cardiovascular studies, along with her leadership roles and volunteer contributions, demonstrate her dedication to advancing both medical practice and community health.

📚 ACADEMIC CITES

Key Publications:

  1. Huang X, et al. “Association of Body Mass Index and Abdominal Obesity with Incidence of Atrial Fibrillation in Heart Failure with Preserved Ejection Fraction.” Current Medical Research and Opinion, 2025.

  2. Huang Jingjing, Huang Xinyi, et al. “Distribution of HDL Subgroups in Patients with H-type Hypertension and Its Impact on the Anti-inflammatory Function of Endothelial Cells.” Chinese Journal of Arteriosclerosis, 2023.

These publications are frequently cited by researchers exploring the links between metabolic dysfunction, arrhythmias, and cardiovascular inflammation.

🏅 AWARDS AND HONORS

  • Excellence Award, 4th National Undergraduate Anesthesiology Knowledge Competition (2018)

  • First Prize, Anesthesiology Imaging Professional Skills Competition Finals (2018)

  • Moral and Ethical Scholarship, Guangdong Medical University (2019)

  • Excellent Student Cadre, Guangdong Medical University (2017-2019)

  • Third-class Scholarship, Sun Yat-sen University (2020-2022)

  • Multiple awards recognizing her volunteerism, refereeing, and leadership contributions.

🌱 LEGACY AND FUTURE CONTRIBUTIONS

Looking ahead, Dr. Huang aspires to advance clinical strategies for obesity management in cardiovascular care, aiming to reduce the global burden of atrial fibrillation. She also seeks to explore AI-driven statistical tools and big data analytics to better predict cardiovascular outcomes.

With a strong passion for photography and life documentation, she continues to balance her rigorous scientific career with creative pursuits, inspiring a holistic approach to well-being and professional fulfillment.

📑 NOTABLE PUBLICATION

"Association of Body Mass Index and Abdominal Obesity with Incidence of Atrial Fibrillation in Heart Failure with Preserved Ejection Fraction"

Authors: Xinyi Huang; Xiao Liu; Yuan Jiang; Zhengyu Cao; Maoxiong Wu; Zhiteng Chen; Runlu Sun; Peng Yu; Jianyong Ma; Wengen Zhu
Journal: Current Medicinal Chemistry
Year: 2025